Sept. 2, 2021
We just discovered two new medical weight loss companies: Options and Calibrate. Options has brick & mortar sites, while Calibrate is a virtual program. Apparently, there’s a lot of venture capital money out there looking for start-ups, and the weight loss space is enticing.
Calibrate claims to have raised $127 million from six venture capital investors, and has grown rapidly as a telemedicine start-up. it has 170 employees and an advisory board. Isabelle Kenyon is the founder and CEO. Website: joincalibrate.com. Entering its second year of business, Calibrate looks to build out its enterprise business in addition to its already established consumer-facing business. Coupled with the rise of telemedicine amid the pandemic, the platform has attracted new users and investors.
Calibrate is offering doctor-prescribed, FDA-approved GLP-1 medication, paired with intensive lifestyle intervention (a comprehensive, fully integrated program combining curriculum and 1:1 coaching, metabolic tracking and community, and telemedicine) straight to its members. Unlike other weight-loss drugs, the FDA-approved GLP-1 medications that Calibrate doctors prescribe work on the same receptors as naturally occurring hormones. They address systems
core to metabolic health, while simultaneously influencing blood sugar response and insulin.
Calibrate provides bi-weekly 1:1 video coaching sessions through a structured curriculum to set goals for the Four Pillars of Metabolic Health: food, sleep, exercise, and emotional health
The average weight loss for a Calibrate member is 14% versus the 10% average seen with GLP-1s plus lifestyle intervention in clinical trials. Calibrate uses manufacturer patient access programs for eligible patients to bring cost to
$25/month or less. These programs are subject to change, and members are eligible for a refund on the program, minus the $249 Metabolic Assessment cost.
The program costs $129/month, with one year’s service billed up front ($1,550). Not everyone is eligible to use Calibrate…
- You have to be within the ages of 18 to 64 years.
- You must have a BMI of at least 30 kg/m2 or have a BMI of 27 kg/m2 with a qualifying metabolic condition.
- You must have commercial or employer-provided health insurance.
- Calibrate is not available in all states, so you must live in a state where Calibrate’s services are available. (A full list of states is available on their website, and they hope to be available nationwide eventually.)
We have not yet found information about this private company’s revenues, but it is one to watch.
Headquarters: 85 Fifth Avenue, 8th Floor, New York, NY 10003
Options Weight Loss Clinics
This company operates a chain of 12 medical weight loss clinics in four states (AZ, Chicago, Florida, Ohio). The company offers FDA approved appetite suppressants including Phentermine, as well as other prescriptions used for weight loss, weekly one-on-one weight loss counseling, Lipotronic fat burners, B12 injections, HCG injections, and the Options Diet System™, Options meals and snacks and supplements. Options has over 19 different individually tailored weight loss programs to choose from. Options has prescription and non-prescription programs. Weekly one-on-one counseling sessions are provided.
The company is headquartered in Chicago, IL and the website is: optionsmedicalweightloss.com
For More Information About The Weight Loss Market and Competitors Such as WW, NutriSystem, Medifast, Jenny Craig, Atkins, Profile by Sanford and more…
See Marketdata’s March 2021 report (FS67): “The U.S. Weight Loss & Diet Control Market”, an in-depth 400+ page study published since 1989 that tracks ALL segments of the weight loss market, dieter demographics, trends, 2025 Forecasts and more. Marketdata provides custom weight loss market research and consulting services, and phone consults. Contact John LaRosa, Research Director and Head Consultant, for details (813-971-8080). Find details and Table of Contents for Marketdata’s weight loss reports at: marketdataenterprises.com. A $99, 46-page Overview Summary report is also available (OV4).